Literature DB >> 20582435

Involvement of PTEN/Akt signaling in capsular invasive carcinomas developed in a rat two-stage thyroid carcinogenesis model after promotion with sulfadimethoxine.

Sayaka Kemmochi1, Hitoshi Fujimoto, Gye-Hyeong Woo, Kaoru Inoue, Miwa Takahashi, Kunitoshi Mitsumori, Masao Hirose, Akiyoshi Nishikawa, Makoto Shibutani.   

Abstract

PURPOSE: Rat thyroid follicular cell carcinomas invading into the thyroid capsule are highly produced by promotion with sulfadimethoxine (SDM) in a rat two-stage thyroid carcinogenesis model. In this study, we investigated the participation of phosphoinositide 3-kinase (PI3K) signaling pathway that is associated with malignant phenotypes of many cancers on the development of SDM-induced capsular invasive carcinomas.
METHODS: Thyroid proliferative lesions developed 10 or 15 weeks after promotion with SDM in male F344 rats initiated with N-bis(2-hydroxypropyl)nitrosamine were immunohistochemically analyzed with regard to cellular distribution of phosphatase and tensin homolog (PTEN) and Akt isoforms, as well as their downstream molecules.
RESULTS: Increased expression of PI3K signaling molecules was evident in association with the development of lesion stages from the early focal hyperplasia to the late carcinomas. Capsular carcinomas, and the less frequent parenchymal carcinomas, exclusively expressed phosphorylated, inactive PTEN, and active Akt isoforms, as did their downstream molecules. Among the Akt isoforms, enhanced expression of Akt1 was more prominent than that of Akt2 in both capsular and parenchymal carcinomas.
CONCLUSIONS: Activation of the PI3K pathway through phosphorylation of PTEN promotes the high production of capsular carcinomas as well as the development of less frequent parenchymal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582435     DOI: 10.1007/s00432-010-0931-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression.

Authors:  Elizabeth A Lipscomb; Arthur M Mercurio
Journal:  Cancer Metastasis Rev       Date:  2005-09       Impact factor: 9.264

3.  Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

Authors:  Ioanna G Maroulakou; William Oemler; Stephen P Naber; Philip N Tsichlis
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  mTOR: a protein kinase switching between life and death.

Authors:  Laura Asnaghi; Paola Bruno; Marcella Priulla; Angelo Nicolin
Journal:  Pharmacol Res       Date:  2004-12       Impact factor: 7.658

5.  Development of invasive follicular cell carcinomas in a rat thyroid carcinogenesis model: biological impact of capsular inflammation and reduced cyclooxygenase-2 expression.

Authors:  Toshio Imai; Mai Hasumura; Jun-ichi Onose; Makoto Ueda; Tamotsu Takizawa; Young-Man Cho; Masao Hirose
Journal:  Cancer Sci       Date:  2005-01       Impact factor: 6.716

6.  PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors:  C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

7.  Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway.

Authors:  Shawn D Larson; Lindsey N Jackson; Taylor S Riall; Tatsuo Uchida; Robert P Thomas; Suimin Qiu; B Mark Evers
Journal:  J Am Coll Surg       Date:  2007-02-23       Impact factor: 6.113

8.  Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.

Authors:  Jeffrey C Horowitz; Daniel Y Lee; Meghna Waghray; Venkateshwar G Keshamouni; Peedikayil E Thomas; Hengmin Zhang; Zongbin Cui; Victor J Thannickal
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

9.  Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells.

Authors:  Galatea Kallergi; Dimitris Mavroudis; Vassilis Georgoulias; Christos Stournaras
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

10.  Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase.

Authors:  Matías Blaustein; Federico Pelisch; Omar A Coso; Mina J Bissell; Alberto R Kornblihtt; Anabella Srebrow
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

View more
  3 in total

1.  Direct progression of capsular invasive carcinomas from subcapsular focal hyperplasias induced by hypothyroidism-mediated tumor promotion in a rat two-stage thyroid carcinogenesis model.

Authors:  Kyohei Ago; Sayaka Kemmochi; Reiko Morita; Atsunori Yafune; Ayako Shiraki; Kunitoshi Mitsumori; Makoto Shibutani
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-01       Impact factor: 4.553

2.  Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma.

Authors:  Berna B Duman; Oğuz I Kara; Aysum Uğuz; Berna T Ates
Journal:  Contemp Oncol (Pozn)       Date:  2014-07-04

Review 3.  The PI3K/Akt Pathway in Tumors of Endocrine Tissues.

Authors:  Helen Louise Robbins; Angela Hague
Journal:  Front Endocrinol (Lausanne)       Date:  2016-01-11       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.